A Secret Weapon For "3
These trials confirmed clinically important pharmacokinetic interactions [7] characterized by a lessen within the clearance with the anticancer drug and therefore greater exposure. The interpretation of subsequent phase II and III clinical trials was intricate as it was impossible to administer exactly the same dose of chemotherapy in the existence